8562 Federal Register / Vol. 87, No. 31 / Tuesday, February 15, 2022 / Notices 

a medical exception to the COVID–19 

vaccination requirement. 

DATES: As of February 15, 2022, the 

notice published January 25, 2022 (87 

FR 3759), is withdrawn. Comments on 

this notice of intent must be submitted 

on or before April 18, 2022. 

ADDRESSES: Interested persons are 

invited to submit written comments to 

the Department of Commerce, PRA 

Clearance Officer at PRAcomments@

doc.gov. All comments received are part 

of the public record. Comments will 

generally be posted without change. All 

Personally Identifiable Information (for 

example, name and address) voluntarily 

submitted by the commenter may be 

publicly accessible. Do not submit 

Confidential Business Information or 

otherwise sensitive or protected 

information. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional information 

should be directed to the Attn: Zack 

Schwartz, Chief of Staff to the Acting 

CFO and Assistant Secretary for 

Administration, Commerce 

Headquarters, at (202) 577–1769; or via 

email: ZSchwartz@doc.gov. 

SUPPLEMENTARY INFORMATION: This 

notice supersedes the notice published 

on January 25, 2022 (87 FR 3759), which 

the Department withdraws. 

Under Executive Order 14043, every 

Federal agency must ‘‘implement, to the 

extent consistent with applicable law, a 

program to require COVID–19 

vaccination for all of its Federal 

employees, with exceptions only as 

required by law.’’ In following this 

directive, the Department imposed a 

requirement that its employees must 

receive and submit proof of COVID–19 

vaccination. As required by 29 U.S.C. 

701 et seq. and 29 CFR part 1630, the 

Department allows an exception from 

the vaccination requirement for 

employees who demonstrate medical 

reasons or disabilities that would make 

the COVID–19 vaccine unsafe for them. 

To obtain this exception, employees can 

submit the Request for Medical 

Exception to the COVID–19 Vaccination 

Requirement form available from the 

Department’s COVID–19 Information 

Hub. The Department uses the 

information on this form to verify 

employees’ assertions that they are 

entitled to an exception to the COVID– 

19 vaccination requirement because of 

their medical or disability statuses. 

OMB Control Number: 0690–0036. 

Form Number(s): None. 

Type of Review: Regular submission; 

Extension of an already approved 

collection. 

Affected Public: Federal employees 

and medical providers. 

Estimated Number of Respondents: 

1,000. 

Estimated Time per Response: 10 

minutes. 

Estimated Total Annual Burden 

Hours: 167. 

Estimated Total Annual Cost to 

Public: $9,321. 

Respondent’s Obligation: Voluntary. 

Legal Authority: Executive Order 

(E.O.) 14043. 

We are soliciting public comments to 

permit the Department/Bureau to: (a) 

Evaluate whether the proposed 

information collection is necessary for 

the proper functions of the Department, 

including whether the information will 

have practical utility; (b) Evaluate the 

accuracy of our estimate of the time and 

cost burden for this proposed collection, 

including the validity of the 

methodology and assumptions used; (c) 

Evaluate ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (d) Minimize the 

reporting burden on those who are to 

respond, including the use of automated 

collection techniques or other forms of 

information technology. 

Comments that you submit in 

response to this notice are a matter of 

public record. We will include or 

summarize each comment in our request 

to OMB to approve this information 

collection request. Before including 

your address, phone number, email 

address, or other personal identifying 

information in your comment, you 

should be aware that your entire 

comment—including your personal 

identifying information—may be made 

publicly available at any time. While 

you may ask us in your comment to 

withhold your personal identifying 

information from public review, we 

cannot guarantee that we will be able to 

do so. 

A Notice Regarding Injunctions: The 

vaccination requirement issued 

pursuant to E.O. 14043, ‘‘Requiring 

Coronavirus Disease 2019 Vaccination 

for Federal Employees’’ is currently the 

subject of a nationwide injunction. 

While that injunction remains in place, 

the Department will not process 

requests for a medical exception from 

the COVID–19 vaccination requirement 

pursuant to E.O. 14043. The Department 

will also not request the submission of 

any medical information related to a 

request for an exception from the 

vaccination requirement pursuant to 

E.O. 14043 while the injunction remains 

in place. But the Department may 

nevertheless receive information 

regarding a medical exception. That is 

because, if the Department were to 

receive a request for an exception from 

the COVID–19 vaccination requirement 

pursuant to E.O. 14043 during the 

pendency of the injunction, the 

Department will accept the request, 

hold it in abeyance, and notify the 

employee who submitted the request 

that implementation and enforcement of 

the COVID–19 vaccination requirement 

pursuant to E.O. 14043 is currently 

enjoined and that an exception therefore 

is not necessary so long as the 

injunction is in place. In other words, 

during the pendency of the injunction, 

any information collection related to 

requests for medical exception from the 

COVID–19 vaccination requirement 

pursuant to E.O. 14043 is not 

undertaken to implement or enforce the 

COVID–19 vaccination requirement. 

Sheleen Dumas, 

Department PRA Clearance Officer, Office of 

the Chief Information Officer, Commerce 

Department. 

[FR Doc. 2022–03184 Filed 2–14–22; 8:45 am] 

BILLING CODE 3510–17–P 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[B–3–2022] 

Foreign-Trade Zone (FTZ) 31—Granite 

City, Illinois; Notification of Proposed 

Production Activity; M.M.O. 

Companies, Inc.; (Disassembly of 

Firearms and Ammunition); 

Mascoutah, Edwardsville and 

Collinsville, Illinois 

America’s Central Port District, 

grantee of FTZ 31, submitted a 

notification of proposed production 

activity to the FTZ Board (the Board) on 

behalf of M.M.O. Companies, Inc., 

located in Mascoutah, Edwardsville and 

Collinsville, Illinois within Subzone 

31E. The notification conforming to the 

requirements of the Board’s regulations 

(15 CFR 400.22) was received on 

February 7, 2022. 

Pursuant to 15 CFR 400.14(b), FTZ 

production activity would be limited to 

the specific foreign-status material(s)/ 

component(s) and specific finished 

product(s) described in the submitted 

notification (summarized below) and 

subsequently authorized by the Board. 

The benefits that may stem from 

conducting production activity under 

FTZ procedures are explained in the 

background section of the Board’s 

website—accessible via www.trade.gov/ 

ftz. 

The proposed finished products 

include: Trigger groups, gas piston 

assemblies, sight assemblies, magazines, 

rail attachments, dust cover assemblies, 

muzzle device assemblies, bolt carriers, 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 31 / Tuesday, February 15, 2022 / Notices 8563 

bolts, operating rods, cocking handles, 

carrying handles, foregrips/handguards, 

buttstocks, pistol grips and bayonet lugs 

from military rifles; empty ammunition 

cartridge casings; smokeless 

ammunition powder; ammunition 

primer; slides, hammers, trigger groups, 

sights, magazines, grips, bolt carriers 

and bolts from pistols; foregrips, 

buttstocks, pistol grips, trigger groups, 

gas piston assemblies, sight assemblies, 

magazines, rail attachments, dust cover 

assemblies, muzzle device assemblies, 

bolt carriers, bolts, carrying handles, 

operating rods and cocking handles 

from rifles; and, foregrips, buttstocks, 

pistol grips, trigger groups, gas piston 

assemblies, sight assemblies, magazines, 

rail attachments, dust cover assemblies, 

muzzle device assemblies, bolt carriers, 

bolts, carrying handles, operating rods 

and cocking handles from shotguns 

(duty rate ranges from duty-free to 

4.2%). 

The proposed foreign-status materials 

and components include: Military rifles; 

machine guns; semi-automatic pistols; 

semiautomatic rifles (centerfire); 

military shotguns; semiautomatic 

shotguns; pump action shotguns; and, 

5.56mm, 7.62mm, .223, .50BMG, .308, 

9mm, .45ACP, and .40 ammunition 

(duty rate ranges from duty-free to 

13%). The request indicates that certain 

materials/components are subject to 

duties under Section 301 of the Trade 

Act of 1974 (Section 301), depending on 

the country of origin. The applicable 

Section 301 decisions require subject 

merchandise to be admitted to FTZs in 

privileged foreign status (19 CFR 

146.41). 

Public comment is invited from 

interested parties. Submissions shall be 

addressed to the Board’s Executive 

Secretary and sent to: ftz@trade.gov. The 

closing period for their receipt is March 

28, 2022. 

A copy of the notification will be 

available for public inspection in the 

‘‘Online FTZ Information System’’ 

section of the Board’s website. 

For further information, contact 

Elizabeth Whiteman at 

Elizabeth.Whiteman@trade.gov. 

Dated: February 9, 2022. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2022–03175 Filed 2–14–22; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[S–18–2022] 

Foreign-Trade Zone 123—Denver, 

Colorado; Application for Subzone; 

Kaiser Premier, LLC; Fort Morgan, 

Colorado 

An application has been submitted to 

the Foreign-Trade Zones (FTZ) Board by 

the City and County of Denver, grantee 

of FTZ 123, requesting subzone status 

for the facilities of Kaiser Premier LLC, 

located in Fort Morgan, Colorado. The 

application was submitted pursuant to 

the provisions of the Foreign-Trade 

Zones Act, as amended (19 U.S.C. 81a– 

81u), and the regulations of the FTZ 

Board (15 CFR part 400). It was formally 

docketed on February 9, 2022. 

The proposed subzone would consist 

of the following sites: Site 1 (.77 acres) 

Factory 2—2550 East Bijou Avenue, Fort 

Morgan; Site 2 (.11 acres) Warehouse— 

2431 East Beaver Avenue, Fort Morgan; 

and Site 3 (.90 acres) Factory 3—404 

Industry Dr., Fort Morgan. Production 

activity was authorized for Kaiser 

Premier LLC on August 17, 2021 under 

now-lapsed FTZ 293 (Doc. B–33–2021). 

The proposed subzone would be subject 

to the existing activation limit of FTZ 

123. 

In accordance with the FTZ Board’s 

regulations, Qahira El-Amin of the FTZ 

Staff is designated examiner to review 

the application and make 

recommendations to the Executive 

Secretary. 

Public comment is invited from 

interested parties. Submissions shall be 

addressed to the FTZ Board’s Executive 

Secretary and sent to: ftz@trade.gov. The 

closing period for their receipt is March 

28, 2022. Rebuttal comments in 

response to material submitted during 

the foregoing period may be submitted 

during the subsequent 15-day period to 

April 11, 2022. 

A copy of the application will be 

available for public inspection in the 

‘‘Online FTZ Information Section’’ 

section of the FTZ Board’s website, 

which is accessible via www.trade.gov/ 

ftz. 

For further information, contact 

Qahira El-Amin at Qahira.El-Amin@

trade.gov. 

Dated: February 9, 2022. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2022–03174 Filed 2–14–22; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Charter Amendment of Department of 

Defense Federal Advisory 

Committees—Uniform Formulary 

Beneficiary Advisory Panel 

AGENCY: Department of Defense (DoD). 

ACTION: Charter amendment of federal 

advisory committee. 

SUMMARY: The DoD is publishing this 

notice to announce that it is amending 

the charter for the Uniform Formulary 

Beneficiary Advisory Panel (UFBAP). 

FOR FURTHER INFORMATION CONTACT: Jim 

Freeman, DoD Advisory Committee 

Management Officer, 703–692–5952. 

SUPPLEMENTARY INFORMATION: The 

UFBAP’s charter is being amended in 

accordance with 10 U.S.C. 1074g(c) and 

the Federal Advisory Committee Act 

(FACA) (5 U.S.C., appendix) and 41 CFR 

102–3.50(a). The charter and contact 

information for the UFBAP’s Designated 

Federal Officer (DFO) are found at 

https://www.facadatabase.gov/FACA/ 

apex/FACAPublicAgencyNavigation. 

The UFBAP provides the Secretary of 

Defense, Deputy Secretary of Defense 

(‘‘the DoD Appointing Authority’’), 

through the Under Secretary of Defense 

for Personnel and Readiness (USD(P&R), 

who shall consider the UFBAP’s advice 

and recommendations before 

implementing changes to the uniform 

formulary in accordance with DoD 

policy and procedures. 

Pursuant to 10 U.S.C. 1074g(c)(2), the 

UFBAP is composed of no more than 15 

members and shall include members 

that represent: (a) Nongovernmental 

organizations and associations that 

represent the views and interests of a 

large number of eligible covered 

beneficiaries; (b) Contractors 

responsible for the TRICARE retail 

pharmacy program; (c) Contractors 

responsible for the national mail-order 

pharmacy program; and (d) TRICARE 

network providers. 

Authority to invite or appoint 

individuals to serve on the UFBAP rests 

solely with the DoD Appointing 

Authority for a term of service of oneto-four years, with annual renewals, in 

accordance with DoD policy and 

procedures. No member, unless 

approved by the DoD Appointing 

Authority, may serve more than two 

consecutive terms of service on the 

UFBAP or serve on more than two DoD 

Federal advisory committees at one 

time. The DoD Appointing authority 

shall appoint the UFBAP’s leadership 

from among the membership previously 

approved to serve on the UFBAP in 


lotter on DSK11XQN23PROD with NOTICES1